+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Gynecological Cancers Therapeutics Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • May 2022
  • Region: Global
  • TechNavio
  • ID: 5601922
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the gynecological cancers therapeutics market and it is poised to grow by $ 14.22 bn during 2022-2026, accelerating at a CAGR of 14.67% during the forecast period. The report on the gynecological cancers therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of gynecological cancers, a strong pipeline and new drug approvals, and a rising number of patient assistance programs.

The gynecological cancers therapeutics market analysis includes type segment and geographic landscape.

The analyst's gynecological cancers therapeutics market is segmented as below:

By Type:

  • Uterine cancer
  • Ovarian cancer
  • Cervical cancer
  • Others

By Geographical Landscape:

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emergence of novel therapies as one of the prime reasons driving the gynecological cancers therapeutics market growth during the next few years. Also, availability of advanced diagnostic modalities and rising awareness of gynecological cancers will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on gynecological cancers therapeutics market covers the following areas:
  • Gynecological cancers therapeutics market sizing
  • Gynecological cancers therapeutics market forecast
  • Gynecological cancers therapeutics market industry analysis

The analyst's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gynecological cancers therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Bristol Myers Squibb Co., Clovis Oncology Inc., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ImmunoGen Inc., Johnson and Johnson, Karyopharm Therapeutics Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Siemens Healthcare GmbH, and Teva Pharmaceutical Industries Ltd.. Also, the gynecological cancers therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Uterine cancer - Market size and forecast 2021-2026
Exhibit 28: Chart on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Uterine cancer - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Uterine cancer - Year-over-year growth 2021-2026 (%)
5.4 Ovarian cancer - Market size and forecast 2021-2026
Exhibit 32: Chart on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Ovarian cancer - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Ovarian cancer - Year-over-year growth 2021-2026 (%)
5.5 Cervical cancer - Market size and forecast 2021-2026
Exhibit 36: Chart on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Cervical cancer - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Cervical cancer - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Type
Exhibit 44: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 82: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 93: AbbVie Inc. - Overview
Exhibit 94: AbbVie Inc. - Product / Service
Exhibit 95: AbbVie Inc. - Key offerings
10.4 Amgen Inc.
Exhibit 96: Amgen Inc. - Overview
Exhibit 97: Amgen Inc. - Product / Service
Exhibit 98: Amgen Inc. - Key offerings
10.5 AstraZeneca Plc
Exhibit 99: AstraZeneca Plc - Overview
Exhibit 100: AstraZeneca Plc - Product / Service
Exhibit 101: AstraZeneca Plc - Key news
Exhibit 102: AstraZeneca Plc - Key offerings
10.6 Bristol Myers Squibb Co.
Exhibit 103: Bristol Myers Squibb Co. - Overview
Exhibit 104: Bristol Myers Squibb Co. - Product / Service
Exhibit 105: Bristol Myers Squibb Co. - Key offerings
10.7 Clovis Oncology Inc.
Exhibit 106: Clovis Oncology Inc. - Overview
Exhibit 107: Clovis Oncology Inc. - Business segments
Exhibit 108: Clovis Oncology Inc. - Key offerings
Exhibit 109: Clovis Oncology Inc. - Segment focus
10.8 Daiichi Sankyo Co. Ltd.
Exhibit 110: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 111: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 112: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 113: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 114: Daiichi Sankyo Co. Ltd. - Segment focus
10.9 Eli Lilly and Co.
Exhibit 115: Eli Lilly and Co. - Overview
Exhibit 116: Eli Lilly and Co. - Product / Service
Exhibit 117: Eli Lilly and Co. - Key offerings
10.10 F. Hoffmann La Roche Ltd.
Exhibit 118: F. Hoffmann La Roche Ltd. - Overview
Exhibit 119: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 120: F. Hoffmann La Roche Ltd. - Key news
Exhibit 121: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 122: F. Hoffmann La Roche Ltd. - Segment focus
10.11 GlaxoSmithKline Plc
Exhibit 123: GlaxoSmithKline Plc - Overview
Exhibit 124: GlaxoSmithKline Plc - Business segments
Exhibit 125: GlaxoSmithKline Plc - Key news
Exhibit 126: GlaxoSmithKline Plc - Key offerings
Exhibit 127: GlaxoSmithKline Plc - Segment focus
10.12 Merck and Co. Inc.
Exhibit 128: Merck and Co. Inc. - Overview
Exhibit 129: Merck and Co. Inc. - Business segments
Exhibit 130: Merck and Co. Inc. - Key news
Exhibit 131: Merck and Co. Inc. - Key offerings
Exhibit 132: Merck and Co. Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 133: Inclusions checklist
Exhibit 134: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 135: Currency conversion rates for US$
11.4 Research methodology
Exhibit 136: Research methodology
Exhibit 137: Validation techniques employed for market sizing
Exhibit 138: Information sources
11.5 List of abbreviations
Exhibit 139: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Type - Market share 2021-2026 (%)
Exhibits 25: Data Table on Type - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Type
Exhibits 27: Data Table on Comparison by Type
Exhibits 28: Chart on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Uterine cancer - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Uterine cancer - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Ovarian cancer - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Ovarian cancer - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Cervical cancer - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Cervical cancer - Year-over-year growth 2021-2026 (%)
Exhibits 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 44: Market opportunity by Type ($ million)
Exhibits 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 48: Chart on Geographic comparison
Exhibits 49: Data Table on Geographic comparison
Exhibits 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 84: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 86: Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2021 and 2026
Exhibits 88: Overview on Criticality of inputs and Factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Vendors covered
Exhibits 92: Matrix on vendor position and classification
Exhibits 93: AbbVie Inc. - Overview
Exhibits 94: AbbVie Inc. - Product / Service
Exhibits 95: AbbVie Inc. - Key offerings
Exhibits 96: Amgen Inc. - Overview
Exhibits 97: Amgen Inc. - Product / Service
Exhibits 98: Amgen Inc. - Key offerings
Exhibits 99: AstraZeneca Plc - Overview
Exhibits 100: AstraZeneca Plc - Product / Service
Exhibits 101: AstraZeneca Plc - Key news
Exhibits 102: AstraZeneca Plc - Key offerings
Exhibits 103: Bristol Myers Squibb Co. - Overview
Exhibits 104: Bristol Myers Squibb Co. - Product / Service
Exhibits 105: Bristol Myers Squibb Co. - Key offerings
Exhibits 106: Clovis Oncology Inc. - Overview
Exhibits 107: Clovis Oncology Inc. - Business segments
Exhibits 108: Clovis Oncology Inc. - Key offerings
Exhibits 109: Clovis Oncology Inc. - Segment focus
Exhibits 110: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 111: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits 112: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 113: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 114: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits 115: Eli Lilly and Co. - Overview
Exhibits 116: Eli Lilly and Co. - Product / Service
Exhibits 117: Eli Lilly and Co. - Key offerings
Exhibits 118: F. Hoffmann La Roche Ltd. - Overview
Exhibits 119: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 120: F. Hoffmann La Roche Ltd. - Key news
Exhibits 121: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 122: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 123: GlaxoSmithKline Plc - Overview
Exhibits 124: GlaxoSmithKline Plc - Business segments
Exhibits 125: GlaxoSmithKline Plc - Key news
Exhibits 126: GlaxoSmithKline Plc - Key offerings
Exhibits 127: GlaxoSmithKline Plc - Segment focus
Exhibits 128: Merck and Co. Inc. - Overview
Exhibits 129: Merck and Co. Inc. - Business segments
Exhibits 130: Merck and Co. Inc. - Key news
Exhibits 131: Merck and Co. Inc. - Key offerings
Exhibits 132: Merck and Co. Inc. - Segment focus
Exhibits 133: Inclusions checklist
Exhibits 134: Exclusions checklist
Exhibits 135: Currency conversion rates for US$
Exhibits 136: Research methodology
Exhibits 137: Validation techniques employed for market sizing
Exhibits 138: Information sources
Exhibits 139: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global gynecological cancers therapeutics market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Bristol Myers Squibb Co., Clovis Oncology Inc., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ImmunoGen Inc., Johnson and Johnson, Karyopharm Therapeutics Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Siemens Healthcare GmbH, and Teva Pharmaceutical Industries Ltd.

Commenting on the report, an analyst said: "The latest trend gaining momentum in the market is the emergence of novel therapies."

According to the report , one of the major drivers for this market is the increasing incidence of gynecological cancers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Becton Dickinson and Co.
  • Biocon Ltd.
  • Bristol Myers Squibb Co.
  • Clovis Oncology Inc.
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • ImmunoGen